永安药业
(002365)
| 流通市值：20.23亿 | | | 总市值：24.43亿 |
| 流通股本：2.44亿 | | | 总股本：2.95亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 193,149,436.01 | 242,036,774.3 | 244,645,727.87 | 326,171,803.22 |
| 应收票据及应收账款 | 144,658,543.53 | 173,737,472.81 | 185,435,900.75 | 171,531,494.6 |
| 其中：应收票据 | 729,283.49 | 1,490,060.91 | 4,792,923.83 | 6,058,239.21 |
| 应收账款 | 143,929,260.04 | 172,247,411.9 | 180,642,976.92 | 165,473,255.39 |
| 应收款项融资 | 1,347,000 | 432,335.45 | 38,679 | - |
| 预付款项 | 9,903,947.16 | 5,240,425.63 | 10,022,298.23 | 8,795,929.39 |
| 其他应收款合计 | 5,647,178.95 | 7,764,678.96 | 6,334,242.71 | 6,054,005.66 |
| 存货 | 92,119,067.35 | 85,224,057.41 | 77,613,464.64 | 69,895,984.49 |
| 其他流动资产 | 6,352,397.59 | 4,656,498.03 | 198,368.55 | 1,047,925.75 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,140,158,277.77 | 1,174,427,006.34 | 1,185,566,357.31 | 1,213,596,306.81 |
| 非流动资产: | | | | |
| 长期股权投资 | 74,301,627.11 | 73,030,694.26 | 69,399,380.84 | 68,300,352.29 |
| 固定资产 | 909,322,028.5 | 910,848,801.55 | 901,015,035.25 | 927,635,265.65 |
| 在建工程 | 55,653,283.06 | 55,530,119.18 | 61,592,498.32 | 26,118,014.36 |
| 无形资产 | 80,409,187.55 | 81,261,709.88 | 82,114,232.21 | 82,393,203.12 |
| 商誉 | 517,416.38 | 517,416.38 | 517,416.38 | 517,416.38 |
| 递延所得税资产 | 12,344,310.38 | 12,203,646.32 | 11,712,859.26 | 11,258,628.03 |
| 其他非流动资产 | 5,201,618.78 | 6,736,768.53 | 10,038,205.95 | 17,318,907.02 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,137,749,471.76 | 1,140,129,156.1 | 1,136,389,628.21 | 1,133,541,786.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,277,907,749.53 | 2,314,556,162.44 | 2,321,955,985.52 | 2,347,138,093.66 |
| 流动负债: | | | | |
| 短期借款 | 20,000,000 | 20,000,000 | 11,029,000 | 10,014,861.11 |
| 应付票据及应付账款 | 117,616,035.84 | 130,342,443.94 | 133,304,514.58 | 160,650,811.69 |
| 其中：应付票据 | - | - | 14,700,000 | 31,900,000 |
| 应付账款 | 117,616,035.84 | 130,342,443.94 | 118,604,514.58 | 128,750,811.69 |
| 合同负债 | 19,119,920.99 | 11,919,556.17 | 17,283,273.47 | 15,588,007.55 |
| 应付职工薪酬 | 33,661,799.07 | 29,209,248.72 | 24,728,076.72 | 37,729,276.25 |
| 应交税费 | 6,029,724.65 | 6,661,209.22 | 20,062,655.96 | 10,239,477.48 |
| 其他应付款合计 | 8,304,665.16 | 38,902,998.68 | 8,264,992.1 | 16,079,227.23 |
| 应付股利 | - | 29,282,145 | - | - |
| 其他流动负债 | 3,764,455.66 | 4,082,222.7 | 5,206,948.38 | 6,953,984.12 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 208,496,601.37 | 241,117,679.43 | 219,879,461.21 | 257,255,645.43 |
| 非流动负债: | | | | |
| 递延收益 | 7,134,630.23 | 7,575,008.54 | 8,060,386.85 | 8,500,765.16 |
| 递延所得税负债 | 21,298,748.87 | 22,599,743.58 | 23,515,377.4 | 33,091,243.89 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 28,433,379.1 | 30,174,752.12 | 31,575,764.25 | 41,592,009.05 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 236,929,980.47 | 271,292,431.55 | 251,455,225.46 | 298,847,654.48 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 294,682,500 | 294,682,500 | 294,682,500 | 294,682,500 |
| 资本公积 | 714,430,398.68 | 714,430,398.68 | 712,920,308.95 | 712,920,308.95 |
| 减:库存股 | 24,183,171.45 | 13,230,185.47 | - | - |
| 其他综合收益 | 2,216,858.16 | 2,336,494.38 | 2,310,620.15 | 4,271,652.27 |
| 专项储备 | 21,373,695.84 | 20,352,845.63 | 20,086,367.44 | 18,617,340.5 |
| 盈余公积 | 140,732,457.83 | 140,732,457.83 | 140,732,457.83 | 140,732,457.83 |
| 未分配利润 | 845,261,982.59 | 835,891,956.44 | 841,368,977.45 | 812,688,884.17 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,994,514,721.65 | 1,995,196,467.49 | 2,012,101,231.82 | 1,983,913,143.72 |
| 少数股东权益 | 46,463,047.41 | 48,067,263.4 | 58,399,528.24 | 64,377,295.46 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,040,977,769.06 | 2,043,263,730.89 | 2,070,500,760.06 | 2,048,290,439.18 |
| 负债和股东权益合计 | 2,277,907,749.53 | 2,314,556,162.44 | 2,321,955,985.52 | 2,347,138,093.66 |
| 公告日期 | 2024-10-30 | 2024-08-28 | 2024-04-30 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |